![]() |
市場調査レポート
商品コード
1772674
医薬品ブリスター包装市場の市場規模、シェア、成長分析、タイプ別、材料別、最終用途別、技術別、地域別 - 産業予測、2025年~2032年Pharmaceutical Blister Packaging Market Size, Share, and Growth Analysis, By Type (Primary Packaging, Bottles), By Material (Glass, Aluminum Foil), By End Use, By Technology, By Region -Industry Forecast 2025-2032 - Industry Forecast 2025-2032 |
||||||
|
医薬品ブリスター包装市場の市場規模、シェア、成長分析、タイプ別、材料別、最終用途別、技術別、地域別 - 産業予測、2025年~2032年 |
出版日: 2025年07月11日
発行: SkyQuest
ページ情報: 英文 194 Pages
納期: 3~5営業日
|
医薬品ブリスター包装の世界市場規模は2023年に207億米ドルと評価され、予測期間(2025-2032年)のCAGRは7.6%で、2024年の217億米ドルから2032年には389億9,000万米ドルに成長する見通しです。
世界の医薬品ブリスター包装市場は、製薬・ヘルスケア産業の拡大に牽引されて大きな成長を遂げています。安全性、改ざん防止、効率的な包装ソリューションに対する需要の高まりにより、ブリスター包装はその耐久性、投与量の正確性、視認性から最有力な選択肢となっています。特筆すべき動向としては、持続可能なイノベーションの推進が挙げられ、メーカーは規制要件や環境への配慮に沿った、環境に優しい、リサイクル可能な、生分解性のオプションを開発しています。さらに、小規模な製薬会社は、先進技術、業務の効率化、サービスの向上を活用するため、受託パッケージング機関との提携を模索しています。さらに、包装工程に人工知能を統合することで精度が向上し、ダウンタイムが短縮される一方、新興企業は自動化とスマート技術によってこの分野を再定義し、市場のイノベーションをさらに促進しています。
Global Pharmaceutical Blister Packaging Market size was valued at USD 20.7 billion in 2023 and is poised to grow from USD 21.7 billion in 2024 to USD 38.99 billion by 2032, growing at a CAGR of 7.6% in the forecast period (2025-2032).
The global pharmaceutical blister packaging market is experiencing significant growth driven by the expansion of the pharmaceutical and healthcare industries. The increasing demand for safe, tamper-evident, and efficient packaging solutions has made blister packaging a top choice due to its durability, dosage accuracy, and visibility. A notable trend includes the push for sustainable innovations with manufacturers developing eco-friendly, recyclable, and biodegradable options that align with regulatory requirements and environmental concerns. Additionally, small pharmaceutical companies are seeking partnerships with contract packaging organizations to capitalize on advanced technology, operational efficiencies, and improved service offerings. Furthermore, the integration of artificial intelligence in packaging processes enhances precision and reduces downtime, while startups are redefining the sector through automation and smart technologies, further driving market innovation.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Blister Packaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Blister Packaging Market Segments Analysis
Global Pharmaceutical Blister Packaging Market is segmented by Type, Material, Technology and region. Based on Type, the market is segmented into Primary Packaging and Secondary Packaging and Tertiary Packaging. Based on Material, the market is segmented into Plastics & Polymers, Paper & Paperboard, Glass, Aluminium Foil and Others. Based on Technology, the market is segmented into Cold Forming and Thermoforming. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pharmaceutical Blister Packaging Market
The pharmaceutical industry serves as a crucial driving force behind the growth of the global blister packaging market. As advancements in drug delivery systems progress, there is a marked shift toward unit-dose packaging that guarantees accurate dosages, reduces potential contamination, and fosters improved patient adherence to medication regimens. Blister packs provide essential features such as tamper evidence, safeguarding the product, and facilitating user-friendly handling, positioning them as an ideal choice for both prescription and over-the-counter medications. Additionally, the increasing aging population, along with a surge in chronic health conditions and the development of healthcare infrastructures in emerging economies, further propels the demand for blister packaging solutions.
Restraints in the Global Pharmaceutical Blister Packaging Market
While blister packaging presents various benefits, it requires considerable investment in advanced manufacturing equipment, premium materials, and strict quality control measures. The integration of sustainable and innovative technologies additionally escalates production expenses, posing challenges for small and medium-sized manufacturers, particularly in budget-conscious markets. Additionally, the volatility in the prices of raw materials such as aluminum, PVC, and bioplastics can result in unpredictable costs, further complicating the financial landscape for these producers. Consequently, these factors collectively act as significant constraints, hindering growth and competitiveness in the global pharmaceutical blister packaging market.
Market Trends of the Global Pharmaceutical Blister Packaging Market
The Global Pharmaceutical Blister Packaging market is witnessing a notable trend towards smart and connected packaging solutions. As the industry embraces technological advancements, manufacturers are increasingly integrating digital features like QR codes, RFID tags, and NFC chips into blister packs. This evolution not only enhances product authentication and traceability but also fortifies efforts against counterfeit drugs, ensuring safety and integrity. Additionally, these smart solutions facilitate remote monitoring of patient adherence, crucial in managing chronic diseases and supporting telemedicine initiatives. By harnessing real-time data on usage patterns, pharmaceutical companies can inform future product development, aligning with the growing demand for patient-centric healthcare solutions.